1[1]Ulrich Popma JJ, satler LF, Dilchard AD, er al. Vascular complication after balloon and new device angioplasty. Circulation.1993, 88:1569 ~1578.
2[2]Muller DM, Shamir KJ, Ellis SG, et al. Peripheral vascular complications after conventional and complex percutaneous transluminal angioplasty. Am J Cardiol. 1992,69:63 ~ 68.
3[3]Gerckens U, Cattleaens N, Lampe EG, et al. Management of Arterial Puncture site after Catheterization Procedure: Evaluating a Suture-Mediated Closure device. Am J cardiol. 1999,3:1658 ~ 1662.
4[4]Michalis LK,Rees MR,Patsouras D,et al.A prospective randomized trial comparing the safety efficacy of three commercially available closure dev (angioseal, Vasoseal and Duett), Cardiovasc Intervent Radiol.2002,25:423 ~ 429.
5[5]Randomized comparison of vasoseal and Angioseal clos devices in patients undergoing angiography angioplasty. Catheter Cardiovasc Interv.2002,55:421 ~ 425.
6Kapadia S R, Raymond R, Knopf W, et al. The 6Fr Angio-Seal arterial closure device: results from a multimember prospective registry. Am J Cardiol, 2001, 87:789-91.
7Chevalier B, Lancelin B, Koning R, et al. Effect of a closure device on complication rates in high-local-risk patients: results of a randomized multicenter trial. Catheter Cardiovasc Interv, 2003, 58:285-91.
8Rilling WS, Dicker M. Arterial puncture closure using a collagen plug, I. (Angio-Seal). Tech Vasc Interv Radiol, 2003, 6(2): 76-81.
9Cleveland G, Hill S, Williams S. Arterial puncture closure using a collagen plug, II. (VasoSeal). Tech Vasc Interv Radiol, 2003, 6(2): 82-84.
10Nasu K, Tsuchikane E, Sumitsuji S, et al. Clinical effectiveness of the Prostar XL suture-mediated percutaneous vascular closure device following PCI: results of the Perclose AcceleRated Ambulation and DISchargE (PARADISE) Trial. J Invasive Cardiol, 2003, 15(5): 251-256.